期刊文献+

基质金属蛋白酶(MMP-9)及其抑制剂(TIMP-1)在食管鳞癌中表达的临床意义 被引量:5

Studies on the Clinical Significance of Matrix Metalloproteinase-9 and Tissue Inhibitors of Metalloproteinase-1 Expression in Esophageal Sqamous Carcinoma
下载PDF
导出
摘要 目的:探讨MMP-9及TIMP-1在食管鳞癌中表达的临床意义。方法:采用SP法检测86例食管鳞癌组织及42例正常食管粘膜组织中MMP-9、TIMP-1的表达情况。结果:1)42例正常食管粘膜组织表达阴性。2)MMP-9在食管鳞癌组织中的阳性表达率为65.12%。其中高、中分化和低分化阳性表达率分别为51.06%和82.05%(P<0.01);Ⅰ、Ⅱ期患者和Ⅲ、Ⅳ期患者分别为42.86%和80.39%(P<0.01);淋巴结转移组和无转移组分别为75.81%和37.50%(P<0.01)。3)TIMP-1在食管鳞癌组织中表达的阳性率为39.02%。其中高、中分化和低分化者阳性表达率分别为44.67%和28.21%(P<0.05);Ⅰ、Ⅱ期患者和Ⅲ、Ⅳ期患者分别为54.29%和25.49%(P<0.01);淋巴结转移组和无淋巴结转移组分别为22.58%和75.00%(P<0.01)。4)Kaplan-Meier分析,MMP-9高表达和TIMP-1低表达患者的生存时间明显低于MMP-9低表达和TIMP-1高表达患者(P<0.05)。结论:MMP-9和TIMP-1的表达与食管鳞癌关系密切,对判断其预后可能具有重要意义。 Objective:Studies on the clinical significance of matrix metalloproteinase-9and tissue inhibitors of metalloproteinase-1expression in esophageal sqamous carcinoma ESC.Meth-ods:The expression of MMP-9and TIMP-1of86cases of ESC and that of42cases of nor-mal esophageal mucosa were detected by the method of streptaridin-peroxidase,Results:①There were no expression of MMP-9and TIMP-1in normal esophageal mucosa of42cases.②The ex-pressive rate of MMP-9of ESC was65.12%.The expression of Well-mediate differentiation and poor were51.06%.and82.05%(P<0.01);Ⅰ-Ⅱgrade andⅢ-Ⅳgrade were42.86%and80.39%(P<0.01);The expression of lymph node metastasis and no lymph node metastasis were75.81%and37.50%(P<0.01).③The expressive rate of TIMP-1of ESC was39.02%.The expression of well-mediate differentiaton and poor were44.67%and28.21%(P<0.05);Ⅰ-Ⅱgrade andⅢ-Ⅳgrade were54.29%and25.41%(P<0.01);The expression of lymph node metastasis and no lymph node metastasis were22.58%and75.00%(P<0.01).④Kaplan-Meier show the survival time of high expression of MMP-9and low expression of TIMP-1was lower than that of low expression of MMP-9and high espression of TIMP-1(P<0.05).Conclusion:the expressive rate of MMP-9and TIMP-1was closely related to the esophageal squamous carcinoma,and would be a valuable prognostic marker.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2003年第10期708-711,共4页 Chinese Journal of Clinical Oncology
关键词 食管肿瘤 MMP-9/TIMP-1 免疫组织化学 Esophagealnephasm MMP-9TIMP-1Immunohistochemistry
  • 相关文献

参考文献15

  • 1[1]Ramos De Simone N, Hahn Dantona E, Sipley J, et al. Activation of matrix metalloproteinase-9 (MMP-9) via a converging plasmin/stromelysin-1 cascade enhances tumor cell invasion[J]. J Biol Chem, 1999, 274(19):13066~13076
  • 2[2]Zeng ZS, Guillem JG. Distinct pattern of matrix metalloprotienase-9 and tissue nhibitor of metalloproteinase-1 mRNA expression in humancolorectal cancer[J]. BRJ Cancer, 1995, 72(16):575~582
  • 3[3]Reddy KB, Krueger JS, Kondapaka SB, et al. Mitogen-activated protein kinase(MAPK) regulates the expression of progelatinase (MMP-9) in breast epithelial cells [J]. Int J Cancer,1999,82 (2) :268~ 273
  • 4[4]Garcia RL, Coltrera MD, Gown AM. Analysis of proliferative grade vsiug anti PCNA/ogclin moualoual antibodies in fixed,embedded fissues:comparison with flow cytometric and lysix[J].Am J Pathol, 1989,134(5):733~739
  • 5[5]Schwingshackl A, Duszyk M, Brown N, et al. Human eosinophils release matrix metalloproteinase-9 on stimulation with TNF-alpha[J]. J Allergy Clin Immunol, 1999,104 (5) :983 ~989
  • 6[6]Tokumarn Y, Fujii M, Otani Y, et al. Actiuationof matrix metalloproteinase-2 in head and neck squamous cell carcinoma studies of clinical samples and in vitro cell lines cocultured with fibroblasts[J]. Cancer Lett, 2000, 150(1):15~21
  • 7[7]Collins HM, Morris TM, Watson SA. Spectrum of matrix metalloproteinase expression in primary and metastatic colon cancer: relationship to the tissue inhibitors of metalloproteinases and membrane type-1-matrix metalloproteinase [J]. Br J Cancer, 2001, 84(12): 1664~1670
  • 8[8]Sshgal G, Hua J, Bernhard EJ. Requirement for matrix metalloproteinase-9(gelatinase B) expression in metastasis by murine prostate carcinoma[J]. Am J Pathol, 1998,152(18): 591~596
  • 9李莉,张声,林华,林建银.基质金属蛋白酶和组织金属蛋白酶抑制剂表达失衡与胃癌浸润转移的关系[J].癌症,2002,21(3):305-310. 被引量:57
  • 10[10]Ohashi K, NemotoT, Nakamura K. Increased expression of matrix m etalloproti enase 7and 9and membrane tygel-martix metalloproteinase in esophageal squamous cell carcinomas [J].Cancer, 2000, 88(10):2201~2209

二级参考文献10

  • 1Chesler L, Golde DW, Bersch N, et al. Metalloproteinase inhibition and erythroid potentiation are independent activities of tissue inhibitor of metalloproteinases-1 [J]. Blood, 1995, 86: 4506-4515.
  • 2Aznavoorian S, Murphy AN, Stetler Stevenson WG, et al. Molecular aspects of tumor cell invasion and metastasis [J]. Cancer, 1993, 71:1368-1383.
  • 3Ramos DeSimone N, Hahn Dantona E, Sipley J, et al. Activation of matrix metalloproteinase-9 (MMP-9) via a converging plasmin/stromelysin-1 cascade enhances tumor cell invasion [J]. J Biol Chem, 1999, 274(19):13066-13076.
  • 4Goldverg GJ, Strongin A, Collier IE, et al. Interaction of 92 kDa type Ⅳ collagenase with tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase and activation of proenzyme with stromelysin [J]. J Biol Chem, 1992, 267:4583-4591.
  • 5Watanabe M, Takahashi Y, Ohta T, et al. Inhibition of metastasis in human gastric cancer cells transfected with tissue inhibitor of metalloproteinase 1 gene in nude mice [J]. Cancer 1996, 77:1676-1680.
  • 6Murray GI, Duncan ME, Arbuckle E, et al. Matrix metalloproteinases and their inhibitors in gastric cancer [J]. Gut, 1998, 43: 791-797
  • 7Davies B, Miles DW, Happerefield IC, et al. Activity of type Ⅳ collagenases in benign and malignant breast disease [J]. Br J Cancer, 1993, 67:1126-1131.
  • 8Torii A, Kodera Y, Uesaka K, et al. Plasma concentration of matrix metalloproteinase 9 in gastric cancer [J]. Br J Surg, 1997, 84: 133-136.
  • 9Sier CF, Kubben FJ, Ganesh S, et al. Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma [J]. Br J Cancer, 1996, 74: 413-417.
  • 10Mimori K, Mori M, Shiraishi T, et al. Clinical signification of tissue inhibitor of metalloproteinase expression in gastric carcinoma [J]. Br J Cancer, 1997, 76: 531-536.

共引文献56

同被引文献45

引证文献5

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部